Recombinant adeno-associated virus type 2-mediated gene delivery into the Rpe65-/- knockout mouse eye results in limited rescue

[1]  W. Shen,et al.  Impurity of recombinant adeno-associated virus type 2 affects the transduction characteristics following subretinal injection in the rat , 2004, Vision Research.

[2]  D. Charteris,et al.  Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina , 2003, Gene Therapy.

[3]  K. Narfström,et al.  Gene transfer in the RPE65 null mutation dog: relationship between construct volume, visual behavior and electroretinographic (ERG) results , 2003, Documenta Ophthalmologica.

[4]  I. Constable,et al.  Practical considerations of recombinant adeno‐associated virus‐mediated gene transfer for treatment of retinal degenerations , 2003, The journal of gene medicine.

[5]  W. Hauswirth,et al.  Structural and functional protection of photoreceptors from MNU-induced retinal degeneration by the X-linked inhibitor of apoptosis. , 2003, Investigative ophthalmology & visual science.

[6]  Y. Chérel,et al.  Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  M. Seeliger,et al.  Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog. , 2003, Investigative ophthalmology & visual science.

[8]  Jian-xing Ma,et al.  Correlation of regenerable opsin with rod ERG signal in Rpe65-/- mice during development and aging. , 2002, Investigative ophthalmology & visual science.

[9]  P. Boulanger,et al.  A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and -5. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  Jian-xing Ma,et al.  11-cis-Retinal Reduces Constitutive Opsin Phosphorylation and Improves Quantum Catch in Retinoid-deficient Mouse Rod Photoreceptors* , 2002, The Journal of Biological Chemistry.

[11]  P. Gouras,et al.  Retinal degeneration and RPE transplantation in Rpe65(-/-) mice. , 2002, Investigative ophthalmology & visual science.

[12]  S. Hanein,et al.  Prenatal human ocular degeneration occurs in Leber's congenital amaurosis (LCA2) , 2002, The journal of gene medicine.

[13]  P. Detwiler,et al.  Recovery of Visual Functions in a Mouse Model of Leber Congenital Amaurosis* , 2002, The Journal of Biological Chemistry.

[14]  P. Luthert,et al.  Kinetics of transgene expression in mouse retina following sub-retinal injection of recombinant adeno-associated virus , 2002, Vision Research.

[15]  R. Samulski,et al.  Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad Specificity , 2002, Journal of Virology.

[16]  R. Ali,et al.  Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina. , 2001, Human molecular genetics.

[17]  P. Gouras,et al.  Ultraviolet and middle wavelength sensitive cone responses in the electroretinogram (ERG) of normal and Rpe65 −/− mice , 2001, Vision Research.

[18]  C. Grimm,et al.  New views on RPE65 deficiency: the rod system is the source of vision in a mouse model of Leber congenital amaurosis , 2001, Nature Genetics.

[19]  R. Rando,et al.  The biochemistry of the visual cycle. , 2001, Chemical reviews.

[20]  Jean Bennett,et al.  Gene therapy restores vision in a canine model of childhood blindness , 2001, Nature Genetics.

[21]  F. Liang,et al.  AAV-mediated delivery of ciliary neurotrophic factor prolongs photoreceptor survival in the rhodopsin knockout mouse. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  B. Illi,et al.  Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo , 2000, Gene Therapy.

[23]  B. Lorenz,et al.  Early-onset severe rod-cone dystrophy in young children with RPE65 mutations. , 2000, Investigative ophthalmology & visual science.

[24]  T. Aleman,et al.  Rapid restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindness. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Hunt,et al.  Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy , 2000, Nature Genetics.

[26]  Kotoku Kurachi,et al.  Kinetics of Recombinant Adeno-Associated Virus-Mediated Gene Transfer , 2000, Journal of Virology.

[27]  T. Townes,et al.  Molecular mechanism for silencing virally transduced genes involves histone deacetylation and chromatin condensation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  E. Traboulsi,et al.  Mutational analysis and clinical correlation in Leber congenital amaurosis , 2000, Ophthalmic genetics.

[29]  I. Constable,et al.  Distribution of cathepsin D in human eyes with or without age-related maculopathy. , 1999, Experimental eye research.

[30]  A. Munnich,et al.  Leber congenital amaurosis. , 1999, Molecular genetics and metabolism.

[31]  T. Aleman,et al.  Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  B. Byrne,et al.  Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield , 1999, Gene Therapy.

[33]  A. Munnich,et al.  Different functional outcome of RetGC1 and RPE65 gene mutations in Leber congenital amaurosis. , 1999, American journal of human genetics.

[34]  K. Narfström,et al.  Retinal dystrophy of Swedish briard/briard-beagle dogs is due to a 4-bp deletion in RPE65. , 1999, Genomics.

[35]  I. Constable,et al.  Evaluation of adeno-associated virus-mediated gene transfer into the rat retina by clinical fluorescence photography. , 1999, Human gene therapy.

[36]  D. Bok,et al.  Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle , 1998, Nature Genetics.

[37]  K. Ray,et al.  Congenital stationary night blindness in the dog: common mutation in the RPE65 gene indicates founder effect. , 1998, Molecular vision.

[38]  C. Hamel,et al.  Rat messenger RNA for the retinal pigment epithelium‐specific protein RPE65 gradually accumulates in two weeks from late embryonic days 1 , 1998, FEBS letters.

[39]  V. Sandig,et al.  Reactivation of the Previously Silenced Cytomegalovirus Major Immediate-Early Promoter in the Mouse Liver: Involvement of NFκB , 1998, Journal of Virology.

[40]  Birgit Lorenz,et al.  Mutations in RPE65 cause autosomal recessive childhood–onset severe retinal dystrophy , 1997, Nature Genetics.

[41]  E. Zrenner,et al.  Mutations in RPE65 cause Leber's congenital amaurosis , 1997, Nature Genetics.

[42]  R. Samulski,et al.  AAV as a viral vector for human gene therapy , 1995, Molecular biotechnology.

[43]  K. Narfström,et al.  Slowly progressive changes of the retina and retinal pigment epithelium in briard dogs with hereditary retinal dystrophy , 1994, Documenta Ophthalmologica.

[44]  M. Naash,et al.  Simulation of human autosomal dominant retinitis pigmentosa in transgenic mice expressing a mutated murine opsin gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  E. Harris,et al.  A developmentally regulated microsomal protein specific for the pigment epithelium of the vertebrate retina , 1993, Journal of neuroscience research.

[46]  K. Narfström,et al.  Ultrastructural changes of the retina and the retinal pigment epithelium in Briard dogs with hereditary congenital night blindness and partial day blindness. , 1992, Experimental eye research.

[47]  R. Scharfmann,et al.  Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[48]  E. Rakoczy,et al.  In vivo gene therapy in young and adult RPE65-/- dogs produces long-term visual improvement. , 2003, The Journal of heredity.

[49]  K. Narfström,et al.  Functional and structural evaluation after AAV.RPE65 gene transfer in the canine model of Leber's congenital amaurosis. , 2003, Advances in experimental medicine and biology.

[50]  W. Rascher,et al.  Sustained delivery of therapeutic concentrations of human clotting factor IX – a comparison of adenoviral and AAV vectors administered in utero , 2002, The journal of gene medicine.

[51]  C. Hamel,et al.  [46] Genetic analysis of RPE65: From human disease to mouse model , 2000 .

[52]  C. Hamel,et al.  Genetic analysis of RPE65: from human disease to mouse model. , 2000, Methods in enzymology.

[53]  B. Ekesten,et al.  Hereditary retinal dystrophy in the briard dog: clinical and hereditary characteristics , 1994 .

[54]  C. Bridges.  Retinoids in Photosensitive Systems , 1984 .